Clinical Trial Update: Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating an anti-LewisY chimeric antigen receptor therapy in patients with multiple myeloma, acute myeloid leukemia, or myelodysplastic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Multiple Myeloma
• Myelodysplastic Syndrome

Drugs mentioned

• Anti-LewisY Chimeric Antigen Receptor

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Multiple Myeloma, Acute Myeloid Leukaemia | Phase 1 | Status: UNKNOWN